NIAID Banner Logo Image

HIV Citation List: March 15 - March 28, 2013

PubMed citations

1. Impact of Primary Elvitegravir Resistance-associated Mutations in HIV-1 Integrase on Drug Susceptibility and Viral Replication Fitness. Abram, M.E., R.M. Hluhanich, D.D. Goodman, K.N. Andreatta, N.A. Margot, L. Ye, A. Niedziela-Majka, T.L. Barnes, N. Novikov, X. Chen, E.S. Svarovskaia, D.J. McColl, K.L. White, and M.D. Miller. Antimicrobial Agents and Chemotherapy, 2013. [Epub ahead of print]. PMID[23529738].
[PubMed]. HIV_0315-032813.


2. Interleukin-27 Is a Potent Inhibitor of cis HIV-1 Replication in Monocyte-derived Dendritic Cells via a Type I Interferon-independent Pathway. Chen, Q., S. Swaminathan, D. Yang, L. Dai, H. Sui, J. Yang, R.L. Hornung, Y. Wang, W. Huang da, X. Hu, R.A. Lempicki, and T. Imamichi. PloS One, 2013. 8(3): p. e59194. PMID[23527130].
[PubMed]. HIV_0315-032813.


3. 2-Hydroxyisoquinoline-1,3(2H,4H)-diones (HIDs), Novel Inhibitors of HIV Integrase with a High Barrier to Resistance. Desimmie, B.A., J. Demeulemeester, V. Suchaud, O. Taltynov, M. Billamboz, C. Lion, F. Bailly, S. Strelkov, Z. Debyser, P. Cotelle, and F. Christ. ACS Chemical Biology, 2013. [Epub ahead of print]. PMID[23517458].
[PubMed]. HIV_0315-032813.


4. Design, Synthesis and Docking Studies of New 4-Hydroxyquinoline-3-carbohydrazide Derivatives as anti-HIV-1 Agents. Hajimahdi, Z., R. Zabihollahi, M.R. Aghasadeghi, and A. Zarghi. Drug Research, 2013. [Epub ahead of print]. PMID[23487403].
[PubMed]. HIV_0315-032813.


5. Inhibition of CXCR4 Expression by Recombinant Adenoviruses Containing Anti-sense RNA Resists HIV-1 Infection on MT4 Cell Lines. Li, W.G., W.M. Nie, W.W. Chen, T.J. Jiang, M. Zhao, and X.Y. Xu. Gene, 2013. [Epub ahead of print]. PMID[23510780].
[PubMed]. HIV_0315-032813.


6. Six New Lignans from the Leaves and Stems of Schisandra sphenanthera. Liang, C.Q., J. Hu, R.H. Luo, Y.M. Shi, S.Z. Shang, Z.H. Gao, R.R. Wang, Y.T. Zheng, W.Y. Xiong, H.B. Zhang, W.L. Xiao, and H.D. Sun. Fitoterapia, 2013. [Epub ahead of print]. PMID[23500381].
[PubMed]. HIV_0315-032813.


7. Surfactant Protein D Modulates HIV Infection of Both T-cells and Dendritic Cells. Madsen, J., G.D. Gaiha, N. Palaniyar, T. Dong, D.A. Mitchell, and H.W. Clark. PloS One, 2013. 8(3): p. e59047. PMID[23527085].
[PubMed]. HIV_0315-032813.


8. Conformation-dependent Recognition of HIV gp120 by Designed Ankyrin Repeat Proteins Provides Access to Novel HIV Entry Inhibitors. Mann, A., N. Friedrich, A. Krarup, J. Weber, E. Stiegeler, B. Dreier, P. Pugach, M. Robbiani, T. Riedel, K. Moehle, J.A. Robinson, P. Rusert, A. Pluckthun, and A. Trkola. Journal of Virology, 2013. [Epub ahead of print]. PMID[23487463].
[PubMed]. HIV_0315-032813.


9. A Novel Ribonuclease with HIV-1 Reverse Transcriptase Inhibitory Activity from the Edible Mushroom Hygrophorus russula. Zhu, M., L. Xu, X. Chen, Z. Ma, H. Wang, and T.B. Ng. Applied Biochemistry and Biotechnology, 2013. [Epub ahead of print]. PMID[23494217].
[PubMed]. HIV_0315-032813.

ISI Web of Knowledge Citations

10. Nitroimidazoles Part 8. Synthesis and anti-HIV Activity of New 4-Nitroimidazole Derivatives Using the Suzuki Cross-coupling Reaction (Vol 67b, Pg 925, 2012). Al-Soud, Y.A., N.A. Al-Masoudi, H.H. Al-Suod, and C. Pannecouque. Zeitschrift fur Naturforschung Section B-A Journal of Chemical Sciences, 2012. 67(12): p. 1325-1325. ISI[000315071500014].
[WOS]. HIV_0315-032813.


11. Induction of CC-chemokines with Antiviral Function in Macrophages by the Human T Lymphotropic Virus Type 2 Transactivating Protein, Tax2. Balistrieri, G., C.S. Barrios, L. Castillo, T.C. Umunakwe, C.Z. Giam, H.J. Zhi, and M.A. Beilke. Viral Immunology, 2013. 26(1): p. 3-12. ISI[000315098200002].
[WOS]. HIV_0315-032813.


12. Darunavir Is Predominantly Unbound to Protein in Cerebrospinal Fluid and Concentrations Exceed the Wild-type HIV-1 Median 90 Inhibitory Concentration. Croteau, D., S.S. Rossi, B.M. Best, E. Capparelli, R.J. Ellis, D.B. Clifford, A.C. Collier, B.B. Gelman, C.M. Marra, J. McArthur, J.A. McCutchan, S. Morgello, D.M. Simpson, I. Grant, S. Letendre, and C. Grp. Journal of Antimicrobial Chemotherapy, 2013. 68(3): p. 684-689. ISI[000314893700033].
[WOS]. HIV_0315-032813.


13. Synthesis and Cytotoxicity of a Ruthenium Nitrosyl Nitric Oxide Donor with Isonicotinic Acid and a Cell Penetrating Peptide. Figueiredo, L.E., E.M. Cilli, R.A.S. Molina, E.M. Espreafico, and E. Tfouni. Inorganic Chemistry Communications, 2013. 28: p. 60-63. ISI[000315251700013].
[WOS]. HIV_0315-032813.


14. Monitoring Binding of HIV-1 Capsid Assembly Inhibitors Using (19)F Ligand-and (15)N Protein-based NMR and X-ray Crystallography: Early Hit Validation of a Benzodiazepine Series. Goudreau, N., R. Coulombe, A.M. Faucher, C. Grand-Maitre, J.E. Lacoste, C.T. Lemke, E. Malenfant, Y. Bousquet, L. Fader, B. Simoneau, J.F. Mercier, S. Titolo, and S.W. Mason. ChemMedChem, 2013. 8(3): p. 405-414. ISI[000315379200005].
[WOS]. HIV_0315-032813.


15. A New BET on the Control of HIV Latency. Karn, J. Cell Cycle, 2013. 12(4): p. 545-546. ISI[000314923000009].
[WOS]. HIV_0315-032813.


16. Low-molecular-weight CXCR4 Ligands with Variable Spacers. Narumi, T., H. Aikawa, T. Tanaka, C. Hashimoto, N. Ohashi, W. Nomura, T. Kobayakawa, H. Takano, Y. Hirota, T. Murakami, N. Yamamoto, and H. Tamamura. ChemMedChem, 2013. 8(1): p. 118-124. ISI[000314172100015].
[WOS]. HIV_0315-032813.


17. N-1,N-3-Disubstituted Uracils as Nonnucleoside Inhibitors of HIV-1 Reverse Transcriptase. Novikov, M.S., V.T. Valuev-Elliston, D.A. Babkov, M.P. Paramonova, A.V. Ivanov, S.A. Gavryushov, A.L. Khandazhinskaya, S.N. Kochetkov, C. Pannecouque, G. Andrei, R. Snoeck, J. Balzarini, and K.L. Seley-Radtke. Bioorganic & Medicinal Chemistry, 2013. 21(5): p. 1150-1158. ISI[000314689200014].
[WOS]. HIV_0315-032813.


18. Protocol for a Mammalian Cell-based Assay for Monitoring the HIV-1 Protease Activity. Rajakuberan, C., B.J. Hilton, and R. Wolkowicz. Diagnosis of Sexually Transmitted Diseases: Methods and Protocols, 2012. 903: p. 393-405. ISI[000313569800027].
[WOS]. HIV_0315-032813.


19. Synthesis, Characterisation, Docking Analysis and Biological Evaluation of alpha,alpha '-bis(p-Dimethylaminobenzylidene)-gamma-methylcyclohexanone. Shalini, S., C.R. Girija, P. Karunakar, M.M. Jotani, K.N. Venugopala, and T.V. Venkatesha. Indian Journal of Chemistry Section B-Organic Chemistry Including Medicinal Chemistry, 2013. 52(2): p. 282-288. ISI[000315133300006].
[WOS]. HIV_0315-032813.


20. Verotoxin A Subunit Protects Lymphocytes and T Cell Lines against X4 HIV Infection in Vitro. Shi, P.L., B. Binnington, D. Sakac, Y. Katsman, S. Ramkumar, J. Gariepy, M. Kim, D.R. Branch, and C. Lingwood. Toxins, 2012. 4(12): p. 1517-1534. ISI[000315406800008].
[WOS]. HIV_0315-032813.


21. Identification of a Candidate Therapeutic Autophagy-inducing Peptide. Shoji-Kawata, S., R. Sumpter, M. Leveno, G.R. Campbell, Z.J. Zou, L. Kinch, A.D. Wilkins, Q.H. Sun, K. Pallauf, D. MacDuff, C. Huerta, H.W. Virgin, J.B. Helms, R. Eerland, S.A. Tooze, R. Xavier, D.J. Lenschow, A. Yamamoto, D. King, O. Lichtarge, N.V. Grishin, S.A. Spector, D.V. Kaloyanova, and B. Levine. Nature, 2013. 494(7436): p. 201-206. ISI[000315137700032].
[WOS]. HIV_0315-032813.


22. BST-2/tetherin: Structural Biology, Viral Antagonism, and Immunobiology of a Potent Host Antiviral Factor. Swiecki, M., N.S. Omattage, and T.J. Brett. Molecular Immunology, 2013. 54(2): p. 132-139. ISI[000315253900004].
[WOS]. HIV_0315-032813.


23. Synthesis of Novel 3 '-Methyl-5 '-norcarbocyclic Nucleoside Phosphonates as Potential anti-HIV Agents. Uttaro, J.P., S. Broussous, C. Mathe, and C. Perigaud. Tetrahedron, 2013. 69(9): p. 2131-2136. ISI[000315062900008].
[WOS]. HIV_0315-032813.


24. Branched Peptide Boronic Acids (BPBAs): A Novel Mode of Binding Towards RNA. Zhang, W.Y., D.I. Bryson, J.B. Crumpton, J. Wynn, and W.L. Santos. Chemical Communications, 2013. 49(24): p. 2436-2438. ISI[000315355900016].
[WOS]. HIV_0315-032813.

Patent Citations

25. Compositions Comprising Substituted Perhydro pyrrolopyridines for Treating Viral Diseases. Huberman, E. Patent. 2013. 2012-US52108 2013028890: 50pp.

[Patent]. HIV_0315-032813.


26. Preparation of Pyridine Derivatives as anti-HIV Agents. Liu, X. and X. Chen. Patent. 2013. 2012-10444863 102887887: 19pp.

[Patent]. HIV_0315-032813.


27. Preparation of Octahydropyrrolo[3,4-C]pyrrole Derivatives as HIV Attachment Inhibitors. Wang, T., Z. Zhang, J.F. Kadow, and N.A. Meanwell. Patent. 2013. 2012-US52606 2013033061: 90pp.

[Patent]. HIV_0315-032813.


28. Aryl Naphthalide Lignans as anti-HIV Agents. Zhang, H. and D. Soejarto. Patent. 2013. 2012-US48657 2013019662: 52pp.

[Patent]. HIV_0315-032813.


29. (Hydroxy)pyrimidinone Compounds as HIV-1 Integrase Inhibitors and Their Preparation, Pharmaceutical Compositions and Use in the Treatment of Aids. Zhao, G., S. Yu, N. Nimati, J. Liu, Y. Liu, Y. Li, and Y. Wang. Patent. 2013. 2012-10410936 102911124: 28pp.

[Patent]. HIV_0315-032813.


30. Preparation of Oxoisoindoline sulfonamides as Inhibitors of HIV-1 Integrase. Zhao, X.Z., S.H. Hughes, B.-H.C. Vu, S. Smith, B. Johnson, Y. Pommier, and T.R. Burke, Jr. Patent. 2013. 2012-US48169 2013016441: 119pp.

[Patent]. HIV_0315-032813.

US Patent Office Citations

31. Glyceryl Nucleotides, Method for the Production Thereof and Their Use. Schott, H. and S. Ludwig. Patent. 2004. 2004-US6787525. 14pp.

[USPTO]. HIV_0315-032813.

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: January 2023